Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome.

Dravet syndrome Nav1.1 SK current Scn1a epilepsy optogenetics reticular thalamic nucleus seizures thalamocortical circuits thalamocortical oscillations

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
02 01 2019
Historique:
received: 06 09 2018
revised: 07 11 2018
accepted: 03 12 2018
entrez: 4 1 2019
pubmed: 4 1 2019
medline: 20 3 2020
Statut: ppublish

Résumé

Loss of function in the Scn1a gene leads to a severe epileptic encephalopathy called Dravet syndrome (DS). Reduced excitability in cortical inhibitory neurons is thought to be the major cause of DS seizures. Here, in contrast, we show enhanced excitability in thalamic inhibitory neurons that promotes the non-convulsive seizures that are a prominent yet poorly understood feature of DS. In a mouse model of DS with a loss of function in Scn1a, reticular thalamic cells exhibited abnormally long bursts of firing caused by the downregulation of calcium-activated potassium SK channels. Our study supports a mechanism in which loss of SK activity causes the reticular thalamic neurons to become hyperexcitable and promote non-convulsive seizures in DS. We propose that reduced excitability of inhibitory neurons is not global in DS and that non-GABAergic mechanisms such as SK channels may be important targets for treatment.

Identifiants

pubmed: 30605686
pii: S2211-1247(18)31929-6
doi: 10.1016/j.celrep.2018.12.018
pmc: PMC6555418
mid: NIHMS1517849
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-64.e6

Subventions

Organisme : NINDS NIH HHS
ID : R00 NS078118
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS096369
Pays : United States

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Références

J Clin Invest. 2013 Apr;123(4):1798-808
pubmed: 23524966
Nat Neurosci. 2006 Sep;9(9):1142-9
pubmed: 16921370
J Neurosci. 2018 Sep 5;38(36):7912-7927
pubmed: 30104343
J Neurosci. 2014 Nov 5;34(45):14874-89
pubmed: 25378155
Epilepsia. 2017 Aug;58(8):e111-e115
pubmed: 28556246
Nature. 2016 Apr 7;532(7597):58-63
pubmed: 27007844
PLoS One. 2013 Oct 14;8(10):e77843
pubmed: 24155976
Neuron. 2009 Jun 11;62(5):612-32
pubmed: 19524522
Brain Res. 1980 Nov 3;200(2):341-54
pubmed: 7417821
Epilepsy Res. 2016 Jan;119:20-3
pubmed: 26656780
Ann Neurol. 2014 Sep;76(3):443-56
pubmed: 25042160
Epilepsia. 2011 Apr;52 Suppl 2:35-8
pubmed: 21463277
Nat Neurosci. 2006 Mar;9(3):389-97
pubmed: 16474392
J Neurophysiol. 1987 Jan;57(1):260-73
pubmed: 3559675
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3139-48
pubmed: 25024183
J Neurosci. 2012 Oct 31;32(44):15533-46
pubmed: 23115190
Hum Mutat. 2009 Oct;30(10):E904-20
pubmed: 19585586
Front Syst Neurosci. 2015 Mar 17;9:39
pubmed: 25852498
Nat Neurosci. 2015 Mar;18(3):351-9
pubmed: 25710837
Epilepsia. 2016 Oct;57(10):1651-1659
pubmed: 27554343
Nat Neurosci. 2011 Jul 24;14(9):1118-20
pubmed: 21785436
Behav Brain Res. 2013 Jan 1;236(1):23-29
pubmed: 22944514
J Neurosci. 2007 May 30;27(22):5903-14
pubmed: 17537961
Epilepsia. 2011 Apr;52 Suppl 2:3-9
pubmed: 21463272
J Neurophysiol. 1991 Aug;66(2):635-50
pubmed: 1663538
PLoS Genet. 2016 Oct 21;12(10):e1006398
pubmed: 27768696
Am J Hum Genet. 2001 Jun;68(6):1327-32
pubmed: 11359211
Neuron. 2017 Jan 4;93(1):194-210
pubmed: 27989462
Trends Neurosci. 2016 Oct;39(10):680-693
pubmed: 27589879
Hum Mol Genet. 2013 Dec 1;22(23):4784-804
pubmed: 23922229
Neurobiol Dis. 2015 May;77:141-54
pubmed: 25766678
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14646-51
pubmed: 22908258
J Neurophysiol. 2010 May;103(5):2470-81
pubmed: 20200124
Science. 1993 Jul 16;261(5119):361-4
pubmed: 8392750
Hum Mol Genet. 2007 Dec 1;16(23):2892-9
pubmed: 17881658
Neuron. 2014 Jun 18;82(6):1367-79
pubmed: 24945776
J Neurosci. 2012 Oct 3;32(40):13917-28
pubmed: 23035101
Proc Natl Acad Sci U S A. 1984 Jul;81(14):4586-90
pubmed: 6589612
Nat Neurosci. 2011 Aug 21;14(9):1167-73
pubmed: 21857658
Science. 1993 Oct 29;262(5134):679-85
pubmed: 8235588
J Neurophysiol. 2009 Jul;102(1):203-13
pubmed: 19386752
Neurology. 2013 Sep 24;81(13):1152-8
pubmed: 23975871
Nat Neurosci. 2008 Jun;11(6):683-92
pubmed: 18488023
Epilepsia. 2013 Apr;54(4):625-34
pubmed: 23311867
J Neurophysiol. 1984 Jun;51(6):1196-219
pubmed: 6737028
Nature. 2017 May 11;545(7653):181-186
pubmed: 28467817
J Neurol Sci. 2000 Jan 1;172(1):25-9
pubmed: 10620656
Brain. 2015 Aug;138(Pt 8):2219-33
pubmed: 26017580
Nat Neurosci. 2013 Jan;16(1):64-70
pubmed: 23143518
Science. 1999 Jan 22;283(5401):541-3
pubmed: 9915702
Neurobiol Dis. 2013 Jan;49:211-20
pubmed: 22926190
Nature. 2011 Jul 27;477(7363):171-8
pubmed: 21796121
Schizophr Bull. 2011 Mar;37(2):306-15
pubmed: 21131368
Neuron. 2017 Mar 8;93(5):1165-1179.e6
pubmed: 28238546
J Physiol. 1984 Apr;349:205-26
pubmed: 6737292
J Physiol Paris. 2016 Nov;110(4 Pt A):372-381
pubmed: 28576554
J Neurosci. 2012 Aug 8;32(32):11067-81
pubmed: 22875939
J Neurosci. 2010 Apr 14;30(15):5465-79
pubmed: 20392967
Annu Rev Physiol. 2012;74:245-69
pubmed: 21942705
Brain Res Brain Res Rev. 2004 Aug;46(1):1-31
pubmed: 15297152
J Neurophysiol. 2000 Aug;84(2):1076-87
pubmed: 10938329
J Neurosci. 2002 Mar 15;22(6):2323-34
pubmed: 11896171
J Physiol. 2003 Feb 1;546(Pt 3):801-11
pubmed: 12563005
Cell Rep. 2017 Jun 6;19(10):2130-2142
pubmed: 28591583
J Neurophysiol. 1994 Aug;72(2):803-18
pubmed: 7527077

Auteurs

Stefanie Ritter-Makinson (S)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Alexandra Clemente-Perez (A)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Physiology, University of California, San Francisco, San Francisco, CA 94158, USA; Neurosciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.

Bryan Higashikubo (B)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Frances S Cho (FS)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Physiology, University of California, San Francisco, San Francisco, CA 94158, USA; Neurosciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.

Stephanie S Holden (SS)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Physiology, University of California, San Francisco, San Francisco, CA 94158, USA; Neurosciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.

Eric Bennett (E)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Ana Chkhaidze (A)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Oscar H J Eelkman Rooda (OHJ)

Department of Neuroscience, Erasmus MC, Rotterdam, the Netherlands; Department of Neurosurgery, Erasmus MC, Rotterdam, the Netherlands.

Marie-Coralie Cornet (MC)

Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Pediatrics, Catholic University of Louvain, Louvain, Belgium.

Freek E Hoebeek (FE)

Department of Neuroscience, Erasmus MC, Rotterdam, the Netherlands; Department of Neurosurgery, Erasmus MC, Rotterdam, the Netherlands; NIDOD Institute, Wilhelmina Children's Hospital, University Medical Center Utrecht and Brain Center Rudolf Magnus, Utrecht, the Netherlands.

Kazuhiro Yamakawa (K)

Laboratory for Neurogenetics, RIKEN Brain Science Institute, Wako, Japan.

Maria Roberta Cilio (MR)

Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Bruno Delord (B)

Institut des Systèmes Intelligents et de Robotique (ISIR), Sorbonne University, 4 Place Jussieu, 75005 Paris, France.

Jeanne T Paz (JT)

Gladstone Institute of Neurological Disease, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA; Neurosciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA; Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: jeanne.paz@gladstone.ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH